3D Bioprinting Market Analysis and Forecast to 2031: By Component (3D Bioprinters and Bioink), Application (Skin, Drug Research), End User (Biopharma, Academia), and Region

3D bioprinting is a type of additive manufacturing that can create three-dimensional (3D) living tissue. It is done by using a bi printer to lay down successive layers of cells, extracellular matrix, and biomaterials to create 3D tissue. The cells can be from the patient themselves, which reduces the risk of rejection, or they can be from donors. 3D bioprinting has the potential to create complex organs, such as the heart, that can be used for transplants. It also has the potential to be used for research to create models of diseases, such as cancer.

Key Trends

The three key trends in 3D bioprinting technology are:

1. Increased accuracy and precision: 3D bioprinting technology is becoming increasingly accurate and precise, allowing for the creation of ever-more complex structures.

2. Increased speed: 3D bioprinting technology is becoming faster, allowing for the production of larger and more complex structures in a shorter timeframe.

3. Increased versatility: 3D bioprinting technology is becoming more versatile, allowing for the creation of a wider range of structures and tissues.

Key Drivers

Some of the key drivers of the 3D bioprinting market are as follows:

  1.  Increasing demand for organ and tissue transplantation
  2.  Rising prevalence of chronic diseases
  3.  Technological advancements in 3D bioprinting
  4.  Growing investment in regenerative medicine
Restraints & Challenges

The key restraints and challenges in 3D Bioprinting market are the high cost of 3D bioprinters and the lack of regulation around the use of 3D bioprinting technology.

3D bioprinters can cost upwards of $100,000, which makes them inaccessible to many researchers and scientists.

In addition, there is currently no regulation around the use of 3D bioprinting technology, which means that there is a lack of standards for quality and safety. This lack of regulation could lead to the misuse of 3D bioprinting technology, which could have negative consequences for human health and the environment.

Market Segments

The 3D Bioprinting Market is segmented by component, application, end-user and region. By component, the market is divided into 3D bioprinters and bioink. Based on application, it is segmented into skin and drug research. On the basis of end-user, it is bifurcated into biopharma and academia. Region-wise the market is divided into North America, Europe, Asia-Pacific, and the Rest of the World.

Key Players

The 3D Bioprinting Market includes players such as EnvisionTEC, Inc., Organovo Holdings, Inc., Inventia Life Science PTY LTD, Poietis, Vivax Bio, LLC, Allevi, Cyfuse Biomedical K.K., 3D Bioprinting Solutions, Cellink Global and Regemat 3D S.L.

Why GIS?

Table of Contents

Chapter 1. Market Introduction
1.1. Objectives of the Study
1.2. Market Definition and Research & Scope
1.3. Research Methodologies
1.4. Market Estimation Techniques

Chapter 2. Executive Summary
2.1. Summary
2.2. Key Highlights of the Market

Chapter 3. 3D Bioprinting Market Outlook
3.1. 3D Bioprinting Market segmentation
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.1.1. Driver 1
3.2.1.2. Driver 2
3.2.1.3. Driver 3
3.2.2. Market Restraints
3.2.2.1. Restraint 1
3.2.2.2. Restraint 2
3.2.3. Market Opportunities
3.2.3.1. Opportunity 1
3.2.3.2. Opportunity 2
3.3. Porter’s Five Forces Analysis
3.3.1. Threat of New Entrants
3.3.2. Threat of Substitutes
3.3.3. Bargaining Power of Buyers
3.3.4. Bargaining Power of Supplier
3.3.5. Competitive Rivalry
3.4. PESTLE Analysis
3.5. Value Chain Analysis
3.5.1. Raw Material Suppliers
3.5.2. Manufacturers
3.5.3. Wholesalers and/or Retailers
3.6. Impact of the Russia and Ukraine War on the 3D Bioprinting Market

Chapter 4. Economic Impact of COVID-19
4.1. Overall Impact of COVID-19
4.2. Impact of COVID On the 3D Bioprinting Market
4.3. Economic Impact Analysis

Chapter 5. 3D Bioprinting Market by Component
5.1. Market Overview
5.2. 3D Bioprinters
5.2.1. Market Size and Forecast, 2021-2031 ($Million)
5.2.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
5.3. Bioinks
5.3.1. Market Size and Forecast, 2021-2031 ($Million)
5.3.2. Market Size and Forecast, by Region, 2021-2031 ($Million)

Chapter 6. 3D Bioprinting Market by Application
6.1. Market Overview
6.2. Skin
6.2.1. Market Size and Forecast, 2021-2031 ($Million)
6.2.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
6.3. Drug Research
6.3.1. Market Size and Forecast, 2021-2031 ($Million)
6.3.2. Market Size and Forecast, by Region, 2021-2031 ($Million)

Chapter 7. 3D Bioprinting Market by End User
7.1. Market Overview
7.2.Academic Institutes
7.2.1. Market Size and Forecast, 2021-2031 ($Million)
7.2.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
7.3. Biopharmaceuticals Companies
7.3.1. Market Size and Forecast, 2021-2031 ($Million)
7.3.2. Market Size and Forecast, by Region, 2021-2031 ($Million)

Chapter 8. 3D Bioprinting Market, by Region
8.1. Overview
8.2. North America
8.2.1. Key Market Trends and Opportunities
8.2.2. North America 3D Bioprinting Market Size and Forecast by Component, 2021-2031, ($Million)
8.2.3. North America 3D Bioprinting Market Size and Forecast by Application, 2021-2031, ($Million)
8.2.4. North America 3D Bioprinting Market Size and Forecast by End User, 2021-2031, ($Million)
8.2.5. North America 3D Bioprinting Market Size and Forecast by Country, 2021-2031, ($Million)
8.2.6. The U.S.
8.2.6.1. The U.S. 3D Bioprinting Market Size and Forecast by Component, 2021-2031, ($Million)
8.2.6.2. The U.S. 3D Bioprinting Market Size and Forecast by Application, 2021-2031, ($Million)
8.2.6.3. The U.S. 3D Bioprinting Market Size and Forecast by End User, 2021-2031, ($Million)
8.2.7. Canada
8.2.7.1. Canada 3D Bioprinting Market Size and Forecast by Component, 2021-2031, ($Million)
8.2.7.2. Canada 3D Bioprinting Market Size and Forecast by Application, 2021-2031, ($Million)
8.2.7.3. Canada 3D Bioprinting Market Size and Forecast by End User, 2021-2031, ($Million)
8.2.8. Mexico
8.2.8.1. Mexico 3D Bioprinting Market Size and Forecast by Component, 2021-2031, ($Million)
8.2.8.2. Mexico 3D Bioprinting Market Size and Forecast by Application, 2021-2031, ($Million)
8.2.8.3. Mexico 3D Bioprinting Market Size and Forecast by End User, 2021-2031, ($Million)
8.3. Europe
8.3.1. Key Market Trends and Opportunities
8.3.2. Europe 3D Bioprinting Market Size and Forecast by Component, 2021-2031, ($Million)
8.3.3. Europe 3D Bioprinting Market Size and Forecast by Application, 2021-2031, ($Million)
8.3.4. Europe 3D Bioprinting Market Size and Forecast by End User, 2021-2031, ($Million)
8.3.5. Europe 3D Bioprinting Market Size and Forecast by Country, 2021-2031, ($Million)
8.3.6. Germany
8.3.6.1. Germany 3D Bioprinting Market Size and Forecast by Component, 2021-2031, ($Million)
8.3.6.2. Germany 3D Bioprinting Market Size and Forecast by Application, 2021-2031, ($Million)
8.3.6.3. Germany 3D Bioprinting Market Size and Forecast by End User, 2021-2031, ($Million)
8.3.7. France
8.3.7.1. France 3D Bioprinting Market Size and Forecast by Component, 2021-2031, ($Million)
8.3.7.2. France 3D Bioprinting Market Size and Forecast by Application, 2021-2031, ($Million)
8.3.7.3. France 3D Bioprinting Market Size and Forecast by End User, 2021-2031, ($Million)
8.3.8. U.K.
8.3.8.1. U.K. 3D Bioprinting Market Size and Forecast by Component, 2021-2031, ($Million)
8.3.8.2. U.K. 3D Bioprinting Market Size and Forecast by Application, 2021-2031, ($Million)
8.3.8.3. U.K. 3D Bioprinting Market Size and Forecast by End User, 2021-2031, ($Million)
8.3.9. Spain
8.3.9.1. Spain 3D Bioprinting Market Size and Forecast by Component, 2021-2031, ($Million)
8.3.9.2. Spain 3D Bioprinting Market Size and Forecast by Application, 2021-2031, ($Million)
8.3.9.3. Spain 3D Bioprinting Market Size and Forecast by End User, 2021-2031, ($Million)
8.3.10. Italy
8.3.10.1. Italy 3D Bioprinting Market Size and Forecast by Component, 2021-2031, ($Million)
8.3.10.2. Italy 3D Bioprinting Market Size and Forecast by Application, 2021-2031, ($Million)
8.3.10.3. Italy 3D Bioprinting Market Size and Forecast by End User, 2021-2031, ($Million)
8.3.11. Rest of Europe
8.3.11.1. Rest of Europe 3D Bioprinting Market Size and Forecast by Component, 2021-2031, ($Million)
8.3.11.2. Rest of Europe 3D Bioprinting Market Size and Forecast by Application, 2021-2031, ($Million)
8.3.11.3. Rest of Europe 3D Bioprinting Market Size and Forecast by End User, 2021-2031, ($Million)
8.4. Asia-Pacific
8.4.1. Key Market Trends and Opportunities
8.4.2. Asia-Pacific 3D Bioprinting Market Size and Forecast by Country, 2021-2031, ($Million)
8.4.3. Asia-Pacific 3D Bioprinting Market Size and Forecast by Application, 2021-2031, ($Million)
8.4.4. Asia-Pacific 3D Bioprinting Market Size and Forecast by Component, 2021-2031, ($Million)
8.4.5. Asia-Pacific 3D Bioprinting Market Size and Forecast by End User, 2021-2031, ($Million)
8.4.6. China
8.4.6.1. China 3D Bioprinting Market Size and Forecast by Component, 2021-2031, ($Million)
8.4.6.2. China 3D Bioprinting Market Size and Forecast by Application, 2021-2031, ($Million)
8.4.6.3. China 3D Bioprinting Market Size and Forecast by End User, 2021-2031, ($Million)
8.4.7. India
8.4.7.1. India 3D Bioprinting Market Size and Forecast by Component, 2021-2031, ($Million)
8.4.7.2. India 3D Bioprinting Market Size and Forecast by Application, 2021-2031, ($Million)
8.4.7.3. India 3D Bioprinting Market Size and Forecast by End User, 2021-2031, ($Million)
8.4.8. Japan
8.4.8.1. Japan 3D Bioprinting Market Size and Forecast by Component, 2021-2031, ($Million)
8.4.8.2. Japan 3D Bioprinting Market Size and Forecast by Application, 2021-2031, ($Million)
8.4.8.3. Japan 3D Bioprinting Market Size and Forecast by End User, 2021-2031, ($Million)
8.4.9. South Korea
8.4.9.1. South Korea 3D Bioprinting Market Size and Forecast by Component, 2021-2031, ($Million)
8.4.9.2. South Korea 3D Bioprinting Market Size and Forecast by Application, 2021-2031, ($Million)
8.4.9.3. South Korea 3D Bioprinting Market Size and Forecast by End User, 2021-2031, ($Million)
8.4.10. Rest of APAC
8.4.10.1. Rest of APAC 3D Bioprinting Market Size and Forecast by Component, 2021-2031, ($Million)
8.4.10.2. Rest of APAC 3D Bioprinting Market Size and Forecast by Application, 2021-2031, ($Million)
8.4.10.3. Rest of APAC 3D Bioprinting Market Size and Forecast by End User, 2021-2031, ($Million)
8.5. Rest of the World
8.5.1. Key Market Trends and Opportunities
8.5.2. Rest of the World 3D Bioprinting Market Size and Forecast by Component, 2021-2031, ($Million)
8.5.3. Rest of the World 3D Bioprinting Market Size and Forecast by Application, 2021-2031, ($Million)
8.5.4. Rest of the World 3D Bioprinting Market Size and Forecast by End User, 2021-2031, ($Million)
8.5.5. Rest of the World 3D Bioprinting Market Size and Forecast by Country, 2021-2031, ($Million)
8.5.6. Latin America
8.5.6.1. Latin America 3D Bioprinting Market Size and Forecast by Component, 2021-2031, ($Million)
8.5.6.2. Latin America 3D Bioprinting Market Size and Forecast by Application, 2021-2031, ($Million)
8.5.6.3. Latin America 3D Bioprinting Market Size and Forecast by End User, 2021-2031, ($Million)
8.5.7. Middle East
8.5.7.1. Middle East 3D Bioprinting Market Size and Forecast by Component, 2021-2031, ($Million)
8.5.7.2. Middle East 3D Bioprinting Market Size and Forecast by Application, 2021-2031, ($Million)
8.5.7.3. Middle East 3D Bioprinting Market Size and Forecast by End User, 2021-2031, ($Million)
8.5.8. Africa
8.5.8.1. Africa 3D Bioprinting Market Size and Forecast by Component, 2021-2031, ($Million)
8.5.8.2. Africa 3D Bioprinting Market Size and Forecast by Application, 2021-2031, ($Million)
8.5.8.3. Africa 3D Bioprinting Market Size and Forecast by End User, 2021-2031, ($Million)

Chapter 9. Competitive Landscape
9.1. Market Overview
9.2. Market Share Analysis/Key Player Positioning
9.3. Developmental Strategy Benchmarking
9.3.1. New Product Development
9.3.2. Product Launches
9.3.3. Business Expansions
9.3.4. Partnerships, Joint Ventures, and Collaborations
9.3.5. Mergers and Acquisitions

Chapter 10. Company Profiles
10.1. EnvisionTEC, Inc.
10.1.1. Company Snapshot
10.1.2. Financial Performance
10.1.3. Product Offerings
10.1.4. Key Strategic Initiatives
10.1.5. SWOT Analysis
10.2. Organovo Holdings, Inc.
10.2.1. Company Snapshot
10.2.2. Financial Performance
10.2.3. Product offerings
10.2.4. Key Strategic Initiatives
10.2.5. SWOT Analysis
10.3. Inventia Life Science PTY LTD
10.3.1. Company Snapshot
10.3.2. Financial Performance
10.3.3. Product offerings
10.3.4. Key Strategic Initiatives
10.3.5. SWOT Analysis
10.4. Poietis
10.4.1. Company Snapshot
10.4.2. Financial Performance
10.4.3. Product offerings
10.4.4. Key Strategic Initiatives
10.4.5. SWOT Analysis
10.5. Vivax Bio, LLC
10.5.1. Company Snapshot
10.5.2. Financial Performance
10.5.3. Product offerings
10.5.4. Key Strategic Initiatives
10.5.5. SWOT Analysis
10.6. Allevi
10.6.1. Company Snapshot
10.6.2. Financial Performance
10.6.3. Product offerings
10.6.4. Key Strategic Initiatives
10.6.5. SWOT Analysis
10.7. Cyfuse Biomedical K.K.
10.7.1. Company Snapshot
10.7.2. Financial Performance
10.7.3. Product offerings
10.7.4. Key Strategic Initiatives
10.7.5. SWOT Analysis
10.8. 3D Bioprinting Solutions
10.8.1. Company Snapshot
10.8.2. Financial Performance
10.8.3. Product offerings
10.8.4. Key Strategic Initiatives
10.8.5. SWOT Analysis
10.9. Cellink Global
10.9.1. Company Snapshot
10.9.2. Financial Performance
10.9.3. Product offerings
10.9.4. Key Strategic Initiatives
10.9.5. SWOT Analysis
10.10. Regemat 3D S.L.
10.10.1. Company Snapshot
10.10.2. Financial Performance
10.10.3. Product offerings
10.10.4. Key Strategic Initiatives
10.10.5. SWOT Analysis

*The list of company is subject to change during the final compilation of the report

 

 

 

 

 

 

Key Players
  • EnvisionTEC, Inc.
  • Organovo Holdings, Inc.
  • Inventia Life Science PTY LTD
  • Poietis
  • Vivax Bio, LLC
  • Allevi
  • Cyfuse Biomedical K.K.
  • 3D Bioprinting Solutions
  • Cellink Global
  • Regemat 3D S.L.
Market Segments

 By Component

  • 3D Bioprinters
  • Bioinks

By Application

  • Skin
  • Drug Research

By End User

  • Academic Institutes
  • Biopharmas

By Regions

  • North America
    • The U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Rest of the World
    • Latin America
    • Middle East
    • Africa

Order this Report

Have questions about the scope of the report ?

Have specific requirements ?

Budget Constraints ?

Related Reports

3D mapping and modelling is the process of…
Data center construction is the process of designing,…
The global 5G smartphone market was valued at…